Re: Clinical Outcomes of cT1 Micropapillary Bladder Cancer: D. L. Willis, M. I. Fernandez, R. J. Dickstein, S. Parikh, J. B. Shah, L. L. Pisters, C. C. Guo, S. Henderson, B. A. Czerniak, H. B. Grossman, C. P. Dinney and A. M. Kamat J Urol 2015;193:1129-1134

J Urol. 2015 Dec;194(6):1825. doi: 10.1016/j.juro.2015.04.119. Epub 2015 Sep 4.

Authors

Indraneel Banerjee¹, Suresh Yadav¹, Shivam Priyadarshi¹, Vinay Tomar¹

Affiliation

¹ Department of Urology, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.

PMID: 26354883
DOI: 10.1016/j.juro.2015.04.119

No abstract available

Publication types

Letter
Comment

MeSH terms

Adjuvants, Immunologic / therapeutic use*
BCG Vaccine / therapeutic use*
Carcinoma, Papillary / drug therapy*
Carcinoma, Papillary / surgery*
Cystectomy*
Female
Humans
Male
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / surgery*

Substances

Adjuvants, Immunologic
BCG Vaccine